Cascadian Therapeutics, Inc. (CASC)’s Stock Price Trading Update:
Cascadian Therapeutics, Inc. (CASC) ended its day with loss -12.44% and finalized at the price of $3.73. During its last trading session, Stock traded with the total exchanged volume of 0.47 million shares. The average volume stands around 0.3 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 1.58. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. Cascadian Therapeutics, Inc. (CASC) is a part of Healthcare sector and belongs to Biotechnology industry.
USA based company, Cascadian Therapeutics, Inc. (CASC)’s latest closing price distance was -27.53% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -6.54% and 1.54% compared with the 20 Day Moving Average.
Analysts Mean Rating:
Analysts’ mean recommendation for Cascadian Therapeutics, Inc. (CASC) stands at 3.00. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
To review the CASC previous performance, look at its past history, which highlighted below:
During last 5 trades the stock sticks almost -0.80%.
During last one month it showed the change of -4.36%.
During last 3 month it remained at -9.47%.
Along with these its year to date performance is standing at -13.46%.
Important Technical Indicators:
ATR value of company was 0.33. A stock ATR is the difference between the high and low price on any given day. It reveals information about how volatile a stock is. Large ranges indicate high volatility and small ranges indicate low volatility.
Traditional interpretation and usage of the RSI is that RSI values of 70 or above indicate that a security is becoming overbought or overvalued, and therefore may be primed for a trend reversal or corrective pullback in price. On the other side of RSI values, an RSI reading of 30 or below is commonly interpreted as indicating an oversold or undervalued condition that may signal a trend change or corrective price reversal to the upside. Relative Strength Index (RSI) of the company is 48.80. Sudden large price movements can create false buy or sell signals in the RSI. It is, therefore, best used with refinements to its application or in conjunction with other, confirming technical indicators.
The stock volatility for week was 13.38% while for month was 8.51%.The stock, as of last close, traded 17.30% to its 52 week low and was changed -66.03% from its 52 week high. Beta factor, which measures the riskiness of the security, was observed as 2.29. CASC’s value Change from Open was at -11.61% with a Gap of -0.94%.
Earnings per share Details about CASC:
EPS in next five year years is expected to touch 11.00% while EPS growth in past 5 year was 14.10%.
EPS growth estimate for this year is set at -54.70%.